Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC)

CUSIP: 09627Y109

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
65,000,000
Total 13F shares
64,072,815
Share change
-712,470
Total reported value
$5,910,035,943
Put/Call ratio
72%
Price per share
$92.24
Number of holders
255
Value change
-$46,573,724
Number of buys
117
Number of sells
113

Quarterly Holders Quick Answers

What is CUSIP 09627Y109?
CUSIP 09627Y109 identifies BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q4 2023

As of 31 Dec 2023, Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) was held by 255 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 64,072,815 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Rock Springs Capital Management LP, STATE STREET CORP, Pictet Asset Management Holding SA, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, and T. Rowe Price Investment Management, Inc.. This page lists 255 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.